This phase II study demonstrated the efficacy of osimertinib 80 mg daily in patients with EGFR mutant NSCLC with leptomeningeal disease. The study designed included BICR using the RANO-LM assessment ...

The object, named ASKAP J1832−091, was first spotted emitting X-rays by NASA’s Chandra X-ray Observatory last year during a ...